This inventor holds 3 USPTO granted patents and 1 published patent application and 2 EPO patents. Top assignees: Imperial Innovations Limited, Imperial College Innovations Limited. Active years: 2015-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2015-2020
Title: Guido Franzoso: Innovator in Cancer Diagnosis and Treatment
Introduction
Guido Franzoso is a notable inventor based in London, GB. He has made significant contributions to the field of medical diagnostics and treatment, particularly in relation to cancer. With a total of 3 patents, his work focuses on innovative methods and compounds that aim to improve patient outcomes.
Latest Patents
Franzoso's latest patents include a method of diagnosis and prognosis that involves measuring Gadd45β expression levels in cell samples. This method is particularly useful for diagnosing multiple myeloma and guiding treatment decisions. Additionally, he has developed Gadd45beta targeting agents, which are compounds designed to treat cancer and inflammatory diseases through specific peptide moieties.
Career Highlights
Throughout his career, Franzoso has worked with prominent organizations such as Imperial Innovations Limited and Imperial College Innovations Limited. His expertise in the field has allowed him to contribute to groundbreaking research and development in cancer treatment.
Collaborations
Franzoso has collaborated with notable colleagues, including Laura Tornatore and Menotti Ruvo. These partnerships have further enhanced his research and innovation efforts.
Conclusion
Guido Franzoso's work exemplifies the impact of innovative thinking in the medical field. His patents and collaborations continue to pave the way for advancements in cancer diagnosis and treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile